[
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "PSMA antigen",
        "binding_metric": "IC50",
        "value": "1 x 10\" M",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "affinity constant",
        "value": "10^7 M\"1",
        "unit": "M\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "affinity constant",
        "value": "10^9 M\"1",
        "unit": "M\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "affinity constant",
        "value": "10^11 M\"1",
        "unit": "M\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "K_assoc",
        "value": "10^3",
        "unit": "M^S\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "K_assoc",
        "value": "10^4",
        "unit": "M^S\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "K_assoc",
        "value": "10^5",
        "unit": "M^S\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "K_d",
        "value": "10\"3 s\"1",
        "unit": "s\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "K_d",
        "value": "10\"4 s\"1",
        "unit": "s\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "K_d",
        "value": "10\"5 s\"1",
        "unit": "s\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    },
    {
        "molecule_name": "Prostate-specific membrane antigen",
        "protein_target_name": "PSMA",
        "binding_metric": "K_d",
        "value": "10\"6 s\"1",
        "unit": "s\"1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about lθ\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 μg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 ° M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"
    }
]